The effects of central pro-and anti-inflammatory immune challenges on depressive-like behavior induced by chronic forced swim stress in rats

Behavioural Brain Research

Volumn 247, Issue , 2013, Pages 232-240

  Pan, Yuqin ^a   Lin, Wenjuan ^a   Wang, Weiwen ^a   Qi, Xiaoli ^a   Wang, Donglin ^a   Tang, Mingming ^a  

^a INSTITUTE OF PSYCHOLOGY   (China)

Author keywords

Depressive like behavior; Interleukin 10; Lipopolysaccharide; Stress

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; SACCHARIN; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BEHAVIORAL SCIENCE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; FOOD PREFERENCE; FORCED SWIMMING TEST; IMMUNOSTIMULATION; INFLAMMATION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRIORITY JOURNAL; PROVOCATION TEST; RAT; WEIGHT GAIN; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; IMMUNOLOGY; MENTAL STRESS; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SWIMMING;

ANIMALS; BEHAVIOR, ANIMAL; CYTOKINES; DEPRESSION; INFLAMMATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84876741085     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.03.031     Document Type: Article

References (55)

1. Knapp D.J., Whitman B.A., Wills T.A., Angel R.A., Overstreet D.H., Criswell H.E., et al. Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety. Brain, Behavior, and Immunity 2011, 25(Suppl. 1):S146-S154.
2. Shizuya K., Komori T., Fujiwara R., Miyahara S., Ohmori M., Nomura J. The expressions of mRNAs for interleukin-6 (IL-6) and the IL-6 receptor (IL-6R) in the rat hypothalamus and midbrain during restraint stress. Life Sciences 1998, 62:2315-2320.
3. Shizuya K., Komori T., Fujiwara R., Miyahara S., Ohmori M., Nomura J. The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat. Life Sciences 1997, 61:135-140.
4. You Z., Luo C., Zhang W., Chen Y., He J., Zhao Q., et al. Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression. Behavioural Brain Research 2011, 225:135-141.
5. Grippo A.J., Francis J., Beltz T.G., Felder R.B., Johnson A.K. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiology and Behavior 2005, 84:697-706.
6. Guo J.-Y., Li C.-Y., Ruan Y.-P., Sun M., Qi X.-L., Zhao B.-S., et al. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. European Journal of Pharmacology 2009, 612:54-60.
7. de Paiva V.N., Lima S.N.P., Fernandes M.M., Soncini R., Andrade C.A.F., Giusti-Paiva A. Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice. Behavioural Brain Research 2010, 215:146-151.
8. Arakawa H., Blandino P., Deak T. Central infusion of interleukin-1 receptor antagonist blocks the reduction in social behavior produced by prior stressor exposure. Physiology and Behavior 2009, 98:139-146.
9. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Research 1996, 711:163-174.
10. Dunn A., Swiergiel A. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacology Biochemistry and Behavior 2005, 81:688-693.
11. Larson S.J., Dunn A.J. Behavioral effects of cytokines. Brain, Behavior, and Immunity 2001, 15:371-387.
12. Wang D., Lin W., Pan Y., Kuang X., Qi X., Sun H. Chronic blockade of glucocorticoid receptors by RU486 enhances lipopolysaccharide-induced depressive-like behaviour and cytokine production in rats. Brain, Behavior, and Immunity 2011, 25:706-714.
13. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 2008, 9:46-56.
14. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.G., te Velde A., Figdor C., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. The Journal of Experimental Medicine 1991, 174:915-924.
15. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 2001, 19:683-765.
16. Bluthe R.M., Castanon N., Pousset F., Bristow A., Ball C., Lestage J., et al. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 1999, 24:301-311.
17. Kao C.-H., Huang W.-T., Lin M.-T., Wu W.-S. Central interleukin-10 attenuated lipopolysaccharide-induced changes in core temperature and hypothalamic glutamate, hydroxyl radicals and prostaglandin-E2. European Journal of Pharmacology 2011, 654:187-193.
18. Kubera M., Maes M., Holanf V., Basta-Kaima A., Roman A., Shani J. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokin in C57BL6 mice subjected to the chronic mild stress model of depression. Journal of Affective Disorders 2001, 63:8.
19. Miura H., Ozaki N., Sawada M., Isobe K., Ohta T., Nagatsu T. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress: The International Journal on the Biology of Stress 2008, 11:198-209.
20. Goshen I., Yirmiya R. Interleukin-1 (IL-1): a central regulator of stress responses. Frontiers in Neuroendocrinology 2009, 30:30-45.
21. Wang Y., Lawson M.A., Dantzer R., Kelley K.W. LPS-induced indoleamine 2, 3-dioxygenase is regulated in an interferon-γ-independent manner by a JNK signaling pathway in primary murine microglia. Brain, Behavior, and Immunity 2010, 24:201-209.
22. Goebel M., Baase J., Pithan V., Exton M., Saller B., Schedlowski M., et al. Acute interferon β-1b administration alters hypothalamic-pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects. Psychoneuroendocrinology 2002, 27:881-892.
23. Kubera M., Obuchowicz E., Goehler L., Brzeszcz J., Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:744-759.
24. Song C., Wang H. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:760-768.
25. Gibb J., Hayley S., Gandhi R., Poulter M.O., Anisman H. Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain, Behavior, and Immunity 2008, 22:573-589.
26. Gandhi R., Hayley S., Gibb J., Merali Z., Anisman H. Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors. Brain, Behavior, and Immunity 2007, 21:477-489.
27. Deak T., Bellamy C., D'Agostino L.G. Exposure to forced swim stress does not alter central production of IL-1. Brain Research 2003, 972:53-63.
28. Deak T., Bellamy C., D'Agostino L.G., Rosanoff M., McElderry N.K., Bordner K.A. Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide. Behavioural Brain Research 2005, 160:125-134.
29. Gibb J., Hayley S., Poulter M.O., Anisman H. Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity. Brain, Behavior, and Immunity 2011, 25:468-482.
30. Brydon L., Walker C., Wawrzyniak A., Whitehead D., Okamura H., Yajima J., et al. Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain, Behavior, and Immunity 2009, 23:217-224.
31. Qi X., Lin W., Li J., Li H., Wang W., Wang D., et al. Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiology of Disease 2008, 31:278-285.
32. Qi X., Lin W., Li J., Pan Y., Wang W. The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behavioural Brain Research 2006, 175:233-240.
33. O'Connor J., Lawson M., Andre C., Moreau M., Lestage J., Castanon N., et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2, 3-dioxygenase activation in mice. Molecular Psychiatry 2008, 14:511-522.
34. Wann B.P., Audet M.-C., Gibb J., Anisman H. Anhedonia and altered cardiac atrial natriuretic peptide following chronic stressor and endotoxin treatment in mice. Psychoneuroendocrinology 2010, 35:233-240.
35. Swiergiel A.H., Dunn A.J. Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacology Biochemistry and Behavior 2007, 86:651-659.
36. Mesquita A.R., Correia-Neves M., Roque S., Castro A.G., Vieira P., Pedrosa J., et al. IL-10 modulates depressive-like behavior. Journal of Psychiatric Research 2008, 43:89-97.
37. Harvey D., Smith R., English K., Mahon B., Commins S. Interleukin-10 (IL-10) but not Lipopolysaccharide (LPS) produces increased motor activity and abnormal exploratory patterns while impairing spatial learning in Balb/c mice. Physiology and Behavior 2006, 87:842-847.
38. Spencer S.J., Heida J.G., Pittman Q.J. Early life immune challenge-effects on behavioural indices of adult rat fear and anxiety. Behavioural Brain Research 2005, 164:231-238.
39. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987, 92:180-185.
40. Pan Y.Q., Wang D.L., Lin W.J. Animal research on immunity activation-induced depressive-like behavior: doses and time effects. Acta Psychologica Sinica 2007, 6:1041-1047.
41. Engeland C. The influence of photoperiod and sex on lipopolysaccharide-induced hypoactivity and behavioral tolerance development in meadow voles (Microtus pennsylvanicus). Psychoneuroendocrinology 2003, 28:970-991.
42. Engeland C.G., Kavaliers M., Ossenkopp K.-P. Influence of the estrous cycle on tolerance development to LPS-induced sickness behaviors in rats. Psychoneuroendocrinology 2006, 31:510-525.
43. Franklin A.E., Engeland C.G., Kavaliers M., Ossenkopp K.P. Lipopolysaccharide-induced hypoactivity and behavioral tolerance development are modulated by the light-dark cycle in male and female rats. Psychopharmacology 2003, 170:399-408.
44. Franklin A.E., Engeland C.G., Kavaliers M., Ossenkopp K.P. The rate of behavioral tolerance development to repeated lipopolysaccharide treatments depends upon the time of injection during the light-dark cycle: a multivariable examination of locomotor activity. Behavioural Brain Research 2007, 180:161-173.
45. Song C., Hoeeobin D.F., Leonard B.E. The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL -1beta in rats. Pharnacopsychiatry 2006, 39:88-99.
46. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 2006, 27:24-31.
47. Renault J., Aubert A. Immunity and emotions: lipopolysaccharide increases defensive behaviours and potentiates despair in mice. Brain, Behavior, and Immunity 2006, 20:517-526.
48. Planas A., Gorina R. Signalling pathways mediating inflammatory responses in brain ischaemia. Biochemical Society Transactions 2006, 34:1267-1270.
49. Wang J., Campbell I.L. Cytokine signaling in the brain: putting a SOCS in it?. Journal of Neuroscience Research 2002, 67:423-427.
50. Cao L., Hudson C.A., Moynihan J.A. Chronic foot shock induces hyperactive behaviors and accompanying pro- and anti-inflammatory responses in mice. Journal of Neuroimmunology 2007, 186:63-74.
51. Nava F., Calapai G., Facciola G., Cuzzocrea S., Marciano M., De Sarro A., et al. Effects of interleukin-10 on water intake, locomotory activity, and rectal temperature in rat treated with endotoxin. International Journal of Immunopharmacology 1997, 19:31-38.
52. Oberholzer A., Oberholzer C., Moldawer L.L. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Critical Care Medicine 2002, 30:S58.
53. Rajasingh J., Bord E., Luedemann C., Asai J., Hamada H., Thorne T., et al. IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. The FASEB Journal 2006, 20:2112.
54. Hayley S., Poulter M., Merali Z., Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 2005, 135:659-678.
55. Sartorius N., Üstün T.B., Lecrubier Y., Wittchen H.U. Depression comorbid with anxiety: results from the WHO study on "Psychological disorders in primary health care.". British Journal of Psychiatry 1996, 30:38-40.